Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06403163

Transfusion Surveillance in Anaesthesia

the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Transfusion Reaction Anesthesia Anesthesia; Shock Blood Coagulation Disorder Blood Coagulation Disorders Blood Loss Digestive System Diseases Disease Attributes Emergencies Fresh Blood Stool Gastrointestinal Diseases Gastrointestinal Hemorrhage Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhage Immune System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Shock Side Effect Transfusion Related Complication

Sex eligibility

All sexes

Study type

Observational

Primary location

Université libre de Bruxelles

Anderlecht, 1070, Belgium

Location status: Recruiting

Location contact

Oliver Duranteau, M.D.

CONTACT

[email protected]

+3225553919

Olivier DURANTEAU, M.D.

PRINCIPAL_INVESTIGATOR

About this study

the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.

Patients will be informed at the time of the anaesthesia consultation about the inclusion in the registry.

The data will be collected from the patients' files by the investigators of the centre without modifying their management.

The data collection period will not exceed the period of acute management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients who have received an hemostasis product

Exclusion criteria

  • patient who refused to consent to data analysis and study participation

Treatment and study plan

Transfusion

Procedure

Transfusion of an hemostatic product

Primary outcomes

  1. Hemostatic evolution through transfusion event

    Time frame: 12 hours

    evolution of APTT (seconds)

  2. ROTEM measures evolution through transfusion event

    Time frame: 12 hours

    evolution of APTEMCT (seconds)

  3. Haematologic measures evolution through transfusion event

    Time frame: 12 hours

    evolution of hemoglobin (g/dL)

  4. ionic measures evolution through transfusion event

    Time frame: 12 hours

    evolution of lactate (mmol/L)

Secondary outcomes

  1. Mortality at one month

    Time frame: one month

    Mortality at one month

Sponsors and collaborators

Lead sponsor

Erasme University Hospital

Other

Registry information

Official study title

Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia

Acronym: STAR

Important dates

Study start
2022
Primary completion
2030
Study completion
2030
First posted
May 7, 2024
Registry last updated
Sep 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.